WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

EVALUATE THE EFFICACY OF SHUNTHYADI KWATH IN THE MANAGEMENT OF MUTRASHMARI (UROLITHIASIS) - A CARECOMPLIANT CLINICAL CASE REPORT

Dr. Neeraj Kumar Singh*, Dr. Anumarlapudi Jayaram, Dr. Ishan Parashar, Dr. Elizabeth P. John, Dr. Ashok Kumar Dwivedi

Abstract

Background: Mutrashmari (urolithiasis) is classified as an Ashtamahagada (one of the eight dreadful conditions) due to its agonizing clinical manifestations, unpredictable structural complications, and potential for severe renal parenchymal impairment. Modern surgical interventions like Extracorporeal Shock Wave Lithotripsy (ESWL) and Retrograde Intrarenal Surgery (RIRS) manage mechanical blockages efficiently but fail to resolve the underlying systemic metabolic errors, resulting in a high recurrence rate of up to 50%. This case report evaluates the therapeutic potential of Shunthyadi Kwath, a polyherbal formulation from Bhaishajya Ratnavali, modified with specific Prakshepa Dravyas (medicated additives), as an ambulatory, non-invasive lithontriptic (Ashmaribhedana) and diuretic (Mutrala) option. Case Presentation: A 35-year-old male patient presented with a one-year history of recurrent, sharp right-sided loin-to-groin pain (Shoola), severe dysuria (Mutrakrichra), and burning micturition (Daha). Diagnostic evaluation via Ultrasonography (USG KUB) confirmed a solitary 5.8 mm calculus lodged in the right proximal ureter, causing mild hydoureteronephrosis. The patient was treated with an oral decoction of Shunthyadi Kwath (48 ml administered twice daily) supplemented with Ramatha (Hingu), Yavakshara, and Saindhava Lavana as Prakshepa powders over a 60-day trial window. Results: The patient achieved significant relief from acute renal colic within the first 7 days of treatment. Complete spontaneous expulsion of the 5.8 mm stone was documented on Day 24 via follow-up USG, which also confirmed total resolution of the secondary hydoureteronephrosis. Urinalysis showed clear clinical improvements, with a shift to normal urinary pH and a complete absence of crystal deposits. No adverse drug reactions occurred during the course of therapy. At a 12-month post-procedural follow-up, the patient remained asymptomatic with zero stone recurrence. Conclusion: This clinical case study confirms that Shunthyadi Kwath serves as a safe, cost-efficient, and definitive non-invasive therapeutic option for lower urinary tract calculi. It effectively facilitates stone passage while correcting the underlying metabolic imbalance to help prevent long-term recurrence.

Keywords: Ayurveda, Mutrashmari, Urolithiasis, Shunthyadi Kwath, Ashmaribhedana, Case Report, CARE Guidelines.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More